Gene description
Orthologous
GO biological process
sterol biosynthetic process, oxidation-reduction process, embryo development ending in seed dormancy
GO cellular component
integral component of membrane, integral component of endoplasmic reticulum membrane, nucleus
GO molecular function
delta14-sterol reductase activity, oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor
Metabolic pathway
Protein-protein interaction network
No Interactor
Coexpression network
Differentially expressed condition
15 conditions
Series | Control | Treatment | Log2FC | Adj. P value |
---|---|---|---|---|
GSE17500 | Col, 35S:AFB1, control 0 h | Col, 35S:AFB1, PstDC3000 24 h | -2.12 | 5.22E-06 |
GSE17500 | Col, WT, control 0 h | Col, WT, PstDC3000 24 h | -2.53 | 5.44E-07 |
GSE17500 | Col, miR393, control 0 h | Col, miR393, PstDC3000 24 h | -2.11 | 4.15E-06 |
GSE18978 | Col, WT, control 24 h | Col, WT, PsmES4326 24 h | -2.02 | 1.27E-09 |
GSE37269 | Ei2, WT, control | Ei2, WT, TEV 21 d | -1.67 | 5.60E-03 |
GSE45212 | Col, WT, PstDC3000 AvrRpt2 0 h | Col, WT, PstDC3000 AvrRpt2 12 h | -2.84 | 2.12E-14 |
GSE45212 | Col, WT, PstDC3000 AvrRpt2 0 h | Col, WT, PstDC3000 AvrRpt2 8 h | -2.07 | 2.33E-12 |
GSE45212 | Col, med14, PstDC3000 AvrRpt2 0 h | Col, med14, PstDC3000 AvrRpt2 12 h | -1.94 | 4.41E-12 |
GSE45212 | Col, med14, PstDC3000 AvrRpt2 0 h | Col, med14, PstDC3000 AvrRpt2 4 h | -1.70 | 3.44E-11 |
GSE45212 | Col, med14, PstDC3000 AvrRpt2 0 h | Col, med14, PstDC3000 AvrRpt2 8 h | -2.38 | 2.09E-13 |
GSE45214 | Col, med16, PstDC3000 AvrRpt2 0 h | Col, med16, PstDC3000 AvrRpt2 4 h | -2.10 | 3.15E-15 |
GSE50526 | Col, WT, mock 24 h | Col, WT, A. brassicicola 24 h | -1.57 | 1.25E-02 |
GSE50526 | Col, WT, mock 9 h | Col, WT, A. brassicicola 9 h | -1.58 | 5.42E-03 |
GSE5520 | Col, WT, control 10 h | Col, WT, Cor- 10 h | -1.51 | 8.79E-05 |
GSE5520 | Col, WT, control 24 h | Col, WT, PstDC3000 24 h | -1.55 | 1.64E-04 |
Copyright © 2017 Ziding Zhang's Lab - China Agricultural University. All Rights Reserved.